Stockwinners Market Radar for August 06, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:40 EDT Vaalco Energy reports Q2 production 20.6K BOE/d vs. 19.7K BOE/d last year

20:23 EDT Cathie Wood's ARK Investment buys 196.7K shares of Roku today

18:57 EDT EA says 'Star Wars Jedi: Survivor' coming to Xbox One, PS4 on September 17 - Electronic Arts (EA) announced that 2023 game "Star Wars Jedi: Survivor," which originally released on PC, Xbox Series X/S (MSFT), and PlayStation 5 (SONY), will arrive on Xbox One and PlayStation 4 on September 17, 2024. Reference Link

18:50 EDT DZS to be delisted from Nasdaq - DZS announced, as expected, it received a letter from Nasdaq indicating that the Nasdaq panel has determined to delist the common stock of the company from Nasdaq. The decision indicates that the company failed to meet the August 5 deadline to regain compliance with its periodic filing obligations under Nasdaq Listing Rule 5250(c)(1).

18:48 EDT BioVie announces 1-for-10 reverse stock split - BioVie announced that the company's reverse stock split of its issued and outstanding Class A common stock at an exchange ratio of 1-for-10, is now effective. The company's common stock began trading on a split-adjusted basis and will remain listed on Nasdaq Capital Market under the symbol (BIVI).

18:43 EDT mF International receives noncompliance notice from Nasdaq - mF International announced that the company received a written notification letter from Nasdaq on August 1, notifying the company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification.

18:41 EDT Fuel Tech awarded $5M in air pollution control orders - Fuel Tech announced the receipt of air pollution control, or APC, orders from new and existing customers in Europe and the U.S. These orders, which have an aggregate value of approximately $5M, include the company's first APC award for a renewable energy project.

18:37 EDT VirTra appoints Brandon Cox as CTO - VirTra announced the appointment of Brandon Cox as chief technology officer, effective August 12, reporting to VirTra chairman and CEO John Givens. In this role, Cox will lead the acceleration of VirTra's expansion into data analytics, drive key systems integrations, and lead the development of new products and enhancements to existing ones.

18:35 EDT Sunrun, Tesla partner to support Texas power grid - Sunrun (RUN) announced that it has expanded its support for the energy grid in Texas with a partnership with Tesla Electric, a retail electricity provider operated by Tesla Energy Ventures, a subsidiary of Tesla (TSLA). The partnership has already enrolled more than 150 Sunrun customers in an aggregated power program and will scale up enrollments while dispatching stored solar energy from at-home batteries to rapidly increase available electricity reserves on the grid during periods of high consumption. The ongoing partnership marks Sunrun's first operational aggregated power plant program in the Lone Star State and comes just weeks after Hurricane Beryl caused widespread power outages impacting nearly 3M homes and businesses.

18:03 EDT Aeterna Zentaris announces name change to Cosciens Biopharma - Cosciens Biopharma, formerly Aeterna Zentaris, announces that the company's name has been changed from "Aeterna Zentaris" to "Cosciens Biopharma," effective as of August 6. In addition, the company announces that, effective as of August 9, the company's common shares will begin trading on the Toronto Stock Exchange and Nasdaq Capital Market under the trading symbol "CSCI" and will concurrently cease trading thereon under the former trading symbol "AEZS".

17:52 EDT Agios to receive $1.1B in milestone payments after FDA approval of vorasidenib - Agios Pharmaceuticals announced that the Company will receive a total of $1.1B in milestone payments following the FDA approval of vorasidenib for adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation following surgery, including biopsy, sub-total resection or gross total resection. These payments include a $905M payment from Royalty Pharma in connection with the vorasidenib royalty purchase agreement Agios announced in May and a $200M payment from Servier in connection with Agios' divestiture of its oncology business in 2021. Agios completed the sale of its oncology business to Servier on March 31, 2021. Under the terms of the agreement, Agios received $1.8B in upfront cash, an additional $200 million milestone payment upon FDA approval of vorasidenib, and 15% royalties on potential U.S. net sales of vorasidenib from the first commercial sale through loss of exclusivity. Agios had also retained rights to 5% royalties on U.S. net sales of Servier's TIBSOVO, which it sold for a one-time payment of $131.8M in 2022.

17:50 EDT Apollo Global announces investment in joint venture related to Vale - Apollo announced a definitive agreement under which Apollo-managed affiliates, funds and other long-term investors will invest $600M to acquire a 50% interest in a joint venture entity related to the Vale Oman Distribution Center, or VODC, from Vale. VODC operates a maritime terminal in Sohar, Oman, with a large deep-water jetty and an integrated iron ore blending and distribution center with a nominal capacity of 40 Mtpy. Vale will continue to own 100% of Vale Oman Pelletizing Company. The transaction is expected to close in the second half of 2024 and is subject to customary regulatory approvals.

17:29 EDT W&T Offshore sees Q3 production 30.9-34.9 MBOE per day - Sees FY production 32.5-36.2 MBOE per day

17:22 EDT Mosaic sees FY24 CapEx $1.1B-$1.2B

17:16 EDT SolarWinds to replace SunPower in S&P 600 at open on 8/9 - SunPower has filed for Chapter 11 bankruptcy and is no longer eligible for continued inclusion in the S&P SmallCap 600.

17:09 EDT Clearwater Paper expects to maintain tissue margin improvement achieved in 2023 - FY 2024 operational assumptions vs. FY 2023: Maintaining tissue margin improvement achieved in 2023; $69M-$74M planned major maintenance outage at Lewiston and Augusta sites; $40M-$50M lower paperboard pricing partly offset by lower input costs; $55M-$70M improved paperboard demand and contribution from Augusta. 2024 other assumptions: Interest expense: $63M-$67M; Depreciation and amortization expense: $120M-$125M; CapEx: $115M-$125M, inclusive of Augusta; Effective rate ~25%-26%. Comments taken from investor presentation slides.

17:03 EDT American Lithium names Paul Charlish as new CFO - American Lithium is pleased to announce the appointment of Paul Charlish as Chief Financial Officer effective August 1, 2024. Mr. Charlish, most recently served as Vice President Finance and Corporate Secretary of American Lithium, and has over 35 years of financial experience, including audit and tax in public practice, as well as financial reporting and tax for public companies. He has extensive knowledge of financial reporting in accordance with IFRS, risk management, international tax, ICFR/SOX and internal controls, as well as in-depth knowledge of public equity offerings in Canada. During the course of his career, Mr. Charlish has been a key member of successful management teams in the position of CFO and Corporate Secretary and has also played an instrumental role in mergers, acquisitions, spinouts and divestments for public companies. Mr. Charlish replaces Philip Gibbs who is retiring and will continue to assist the Company in an advisory role.

17:01 EDT Aeries Technology discloses Nasdaq listing letter of deficiency - Aeries Technology announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC on July 31, 2024. The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Annual Report on Form 10-K for the year ended March 31, 2024 as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission on July 1, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.

16:58 EDT Gentherm announces departure of CFO Matteo Anversa - Gentherm announced that its executive VP, CFO and treasurer, Matteo Anversa, has resigned effective September 1, to accept the role of CFO of Logitech International. The company has initiated a CFO succession process, chaired by the president and CEO, and will provide updates as appropriate.

16:55 EDT Hyster-Yale Materials sees y/y revenue growth in 2H24 - The company expects continued year-over-year revenue growth and strong product margins in the second half of 2024 as higher-priced, higher-margin backlog units are shipped. Material and freight cost inflation is expected to somewhat temper the favorable second-half price-to-cost ratio. The combination of these factors and higher operating expenses are expected to reduce second-half operating profit modestly compared with the prior year. The company is closely monitoring the effects of freight and material cost inflation and a weaker U.S. market and will quickly take any additional cost containment actions needed to help offset the negative impacts. Specifically, in Q3 2024, revenues are expected to increase compared to the prior year, while operating profit is expected to be comparable. Sequentially, third-quarter revenues and operating profit are expected to decrease from the strong second-quarter results due to normal business seasonality and modest impacts from freight cost inflation.

16:43 EDT Container Store not providing guidance, cites strategic alternatives evaluation - Container Store said that as the company continues to evaluate strategic alternatives, it is not providing financial guidance. "The Container Store has not set a deadline or definitive timetable for the completion of the strategic alternatives review process, and there can be no assurance that this process will result in any particular outcome. The Container Store does not intend to comment further regarding the review of strategic alternatives until it determines disclosure is necessary or advisable," the company stated. Jeff Miller, Chief Financial Officer, commented, "Second quarter fiscal 2024 to date, our year over year sales decline has improved slightly from the decline we just reported for the first quarter of fiscal 2024. Our performance continues to be driven by relative strength in our Custom Spaces business with year over year growth in our Elfa and Preston product lines. However, our general merchandise category remains challenged resulting in double-digit year-over-year total sales declines, though not of the magnitude reported for the first quarter of fiscal 2024."

16:41 EDT CACI awarded $416M task order from U.S. Army - CACI International announced that it has been awarded a five-year technology task order valued at up to $416M to design, produce, and deliver complex, customized radio frequency systems for U.S. Army's signals intelligence missions. "SIGINT has always been essential to intelligence missions. However, as multi-domain threats evolve at a moment's notice, the Army requires superior integration of modern technologies at the tactical edge," said John Mengucci, CACI President and Chief Executive Officer. "By utilizing our cutting-edge hardware and software systems and our expert analysis, we will give warfighters operational agility through enhanced situational awareness and force protection, as well as increased capacity to outpace our adversaries."

16:40 EDT Enhabit CFO Carlisle to step down - Enhabit announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contributed to the Company achieving stability across the business and positioning our organization for growth. I am grateful for Crissy's partnership and look forward to her continued leadership as we search for her successor."

16:36 EDT Cryoport announces $200M share repurchase plan - The 2024 Repurchase Program became effective on August 1, 2024 and remains in effect through December 31, 2027.

16:35 EDT eHealth announces 2025 CEO succession plan - eHealth announced that Fran Soistman will retire from his role as CEO upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Soistman intends to remain a director on the company's Board of Directors. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Soistman's successor and has engaged Spencer Stuart, a leading executive search firm, to identify and evaluate both internal and external candidates.

16:34 EDT Tidewater board approves additional share buyback of $13.9M - Tidewater's Board approved an additional share repurchase authorization of $13.9M, for a total current outstanding authorized capacity of $47.7M, the maximum permissible amount under existing debt agreements.

16:28 EDT Logitech names Matteo Anversa CFO - Logitech announced that Matteo Anversa will join the Company as chief financial officer (CFO) and member of Logitech's Group Management Team, effective September 1, 2024, reporting to chief executive officer (CEO) Hanneke Faber. "I'm delighted to welcome Matteo to Logitech's leadership team," said Hanneke Faber, Logitech CEO. "As a seasoned public company CFO with a background in engineering and industrial technology, Matteo brings skills and experiences well suited to Logitech. His diverse B2B experience will also be a strong addition to the team as we accelerate our focus on serving a broad range of enterprise customers. And Matteo brings a uniquely global perspective with significant experience drawn from living and working in Asia, Europe and North America."

16:27 EDT Revolve Group sees Q3 Gross margin 52.3%-52.5%

16:24 EDT Inogen jumps 20% to $9.75 after Q2 earnings beat, above-consensus guidance

16:21 EDT VF Corp. affirms FY24 cash flow outlook - The company "reiterates guidance for free cash flow plus the proceeds from non-core physical asset sales of approximately $600 million, excluding the impact of the divestiture of Supreme, which is anticipated to be completed by the end of calendar year 2024. Supreme is expected to be reported as discontinued operations beginning in Q2'FY25."

16:18 EDT Toast sees Q3 adjusted EBITDA $70M-$80M - Sees Q3 Non-GAAP subscription services and financial technology solutions gross profit in the range of $345 million to $355 million, 23%-27% growth compared to Q3 2023.

16:17 EDT Stem initiates strategic review of business

16:14 EDT iRobot names Jeffrey Engel as President & COO - iRobot announced it has named Jeffrey Engel as President & COO. Engel holds more than 30 years of executive and advisory experience, most recently serving as the company's Chief Restructuring Officer. As iRobot's President & COO, Engel will oversee daily operations and be responsible for the company's ongoing restructuring, research and development, operations and supply chain, and product management. He will report directly to Gary Cohen, iRobot CEO.

16:08 EDT Corvus Pharmaceuticals sees cash to fund operations into Q4 - Corvus expects full year 2024 net cash used in operating activities to be between approximately $24M and $27M, resulting in a projected cash balance of between approximately $31M and $34 M at December 31. Based on its current plans, Corvus expects its cash to fund operations into the fourth quarter of 2025. Research and development expenses for the three months ended June 30 totaled $4.1M compared to $4M for the same period in 2023. The increase of $0.1M was primarily due to higher clinical trial costs associated with the development of soquelitinib.

16:00 EDT Armada Acquisition Corp I trading resumes

15:13 EDT Intel announces Clearwater Forest and Panther Lake booted up on Intel 18A - Intel announced in part, earlier on Tuesday ,that "Intel Foundry achieved major milestones... its lead products on Intel 18A, Panther Lake or AI PC client processor, and Clearwater Forest, server processor,, are out of the fab and have powered-on and booted operating systems. These milestones were achieved less than two quarters after tape-out, with both products on track to start production in 2025. The company also announced that the first external customer is expected to tape out on Intel 18A in the first half of next year. "We are pioneering multiple systems foundry technologies for the AI era and delivering a full stack of innovation that's essential to the next generation of products for Intel and our foundry customers. We are encouraged by our progress and are working closely with customers to bring Intel 18A to market in 2025.".. These milestones show Intel Foundry is the first to successfully implement both RibbonFET gate-all-around transistors and PowerVia backside power technology for foundry customers. Through ecosystem EDA and IP tools and process flows, RibbonFET and PowerVia are groundbreaking innovations that Intel Foundry makes available to all customers through Intel 18A. Working in concert with its resilient, more sustainable and trusted manufacturing capacity and supply chain, as well as the industry's leading advanced packaging technology, Intel Foundry brings together all the components needed to design and manufacture next-generation AI solutions that scale and run more efficiently.." Reference Link

14:34 EDT Entravision, NFL announce expanded 3-year deal - Entravision announced the renewal of its "longstanding partnership" with the National Football League through a new three-year radio and audio streaming deal. "This extension marks a significant milestone, celebrating a decade of collaboration between the two organizations and securing the partnership through the 2026-2027 NFL season. This expanded partnership aims to deepen engagement and foster greater affinity for the sport among Latino communities across the U.S., where 71% identify as being fans of the NFL, the largest Latino fan base of any U.S. sports league. The collaboration will continue strengthening efforts to deliver culturally relevant and high-quality sports content that resonates with Latino fans," the company stated.

13:08 EDT Disney announces higher prices for streaming platforms, new channels - Disney+ announced it is adding continuous playlists to its core subscription on-demand offering in the U.S. Beginning September 4, ABC News Live and a playlist focused on preschool content will be available to all subscribers, with four additional curated playlists to follow later this fall. Disney also announced higher prices for most of its streaming plans. "With this growing offering, and new ways to enjoy your favorite Disney+ content, Disney subscription plans remain among the best values in streaming today," the company said in a statement. Most plans for Disney+, Hulu and ESPN+ starting on October 17 will cost $1 to $2 more per month, with the most expensive plans for Hulu, which include live TV, will cost $6 more per month. Disney+ with ads will cost $9.99 per month and without ads will cost $15.99. Hulu will cost $9.99 per month with ads and $18.99 without. Reference Link

13:03 EDT Disney jumps 4% to $91.19 after Bloomberg report of price increases

12:40 EDT Palomar discloses termination of Omaha National contract, will impact growth - On its quarterly earnings call, Palomar announced that in the fourth quarter, fronting premium will decline as one of its key partners, Omaha National, secured the requisite license to do business in California without a front. Termination of the contract will impact the company's fronting segment's growth over the next several quarters as it works to replace the lost business with new partnerships, Palomar said.

12:02 EDT Cabot rises 16.3% - Cabot is up 16.3%, or $14.16 to $101.12.

12:02 EDT Lumen rises 71.7% - Lumen is up 71.7%, or $1.86 to $4.45.

12:00 EDT TrueBlue falls -21.6% - TrueBlue is down -21.6%, or -$2.31 to $8.40.

11:50 EDT WisdomTree subsidiary receives 'Wells Notice' from SEC - In a regulatory filing earlier, WisdomTree disclosed that on August 5, WisdomTree Asset Management, , or "WTAM," a wholly-owned subsidiary of WisdomTree, Inc., received a "Wells Notice" from the staff of the U.S. Securities and Exchange Commission advising WTAM that the Staff has made a "preliminary determination" to recommend that the SEC file an enforcement action against WTAM alleging violations of certain provisions of the U.S. federal securities laws. "The recommendation may involve a civil injunctive action or other action allowed by law, and may seek remedies that include injunctions, disgorgement, pre-judgement interest, civil money penalties and such other relief as may be available. The alleged violations relate to three exchange-traded series of WisdomTree Trust managed by WTAM that pursued ESG-focused investment strategies. The Board of Trustees of WisdomTree Trust, after careful consideration of various factors, including the persistent lack of investor demand and limited prospects for future asset growth, approved the liquidation of the ESG Funds in December 2023. Each ESG Fund completed its liquidation in February 2024. During their periods of operations, the ESG Funds had, in the aggregate, average assets under management of approximately $119 million. A Wells Notice is neither a formal charge of wrongdoing nor a final determination that the recipient has violated any law. WTAM maintains that its actions have been in compliance with all applicable laws and regulations, and intends to pursue the Wells Notice process, which will include the opportunity to respond to the Staff's position," the filing stated. Reference Link

11:06 EDT Nisun Internatnal Entpre Dev Grp Co Ltd trading resumes

11:01 EDT Nisun Internatnal Entpre Dev Grp Co Ltd trading halted, volatility trading pause

10:34 EDT Korber Supply Chain Software to acquire MercuryGate, terms not disclosed - Korber Supply Chain Software, a joint venture between Korber AG and KKR signed a binding agreement to acquire MercuryGate International Inc., a provider of transportation management systems. MercuryGate is known for its strong capabilities in multimodal optimization and execution, as well as its expertise and capabilities in driving rapid implementation and time to value. The acquisition is a strategic move that extends Korber Supply Chain Software's capabilities in delivering a comprehensive, innovative, adaptable and scalable supply chain execution portfolio. The complexities of global supply chains continue to grow, and the need for flexibility and resiliency has never been greater. Operators demand ever-increasing adaptability and scalability in supply chain execution solutions to innovate and expand. By extending its portfolio of solutions across all supply chain execution operations, Korber Supply Chain Software will become a leader in managing the movement of goods from procurement to receipt and fulfillment to the end consumer, reducing planning silos, accelerating resolution of issues, and improving customer and business outcomes. Bringing Korber Supply Chain Software and MercuryGate together will enable customers to benefit from: Solutions that connect across inbound and outbound supply chain activities, improving cost efficiencies and customer experiences by optimizing placement, usage, and routing of goods. A resilient and reliable supply chain platform with visibility across inventory pools, enabling customers to identify growth opportunities as well as predict and rapidly respond to potential disruptions. Simulation capabilities to evaluate future supply chain strategies and understand ROI across their local and global business. The acquisition of MercuryGate will establish a critical pillar of Korber's ambition to create a unified supply chain execution suite that can offer real-time optimization and collaboration across the supply chain. Customers will benefit from integrated processes across functions, faster and more accurate decision-making and the ability to mitigate risks and disruptions more effectively. The transaction is subject to customary closing conditions and regulatory approvals.

10:32 EDT Kingstone Companies trading resumes

10:27 EDT Kingstone Companies trading halted, volatility trading pause

10:03 EDT TENK Stock trading resumes

10:02 EDT IonQ awarded quantum computing contract with ARLIS, first phase valued at $5.7M - IonQ announced that it has won a contract through a competitive solicitation with the Applied Research Laboratory for Intelligence and Security, or ARLIS, to design a first-of-its-kind, networked quantum computing system for the Department of Defense and U.S. Intelligence Community. The first phase of the project - awarded at $5.7M - will focus on the design phase of the quantum system. Future phases of the project, which have yet to be awarded, include the construction, delivery, and maintenance of these systems. Through this project, ARLIS will conduct hands-on research into the cybersecurity of multi-party quantum computation, including blind quantum computing protocols - a process where quantum computers remain 'blind' to what information is being processed through them. This effort is funded by an award from the Secretary of the Air Force Concepts, Development, and Management Office. "With the rapid advancement of technologies like quantum and AI, we as a nation must maintain our leadership position in these developing fields while also hardening our security tools against global actors like China and Russia," said Rep. C.A. Dutch Ruppersberger. "I am pleased to have secured $40M to support this project to bring IonQ's quantum systems to the ARLIS facility, and it's exciting to see the first phase of this project underway, which will guide the DoD's strategy for securing the quantum space."

10:01 EDT Lumen rises 53.5% - Lumen is up 53.5%, or $1.39 to $3.98.

10:01 EDT BAE Systems awarded $48M contract from Air Force Research Laboratory - BAE Systems has been awarded a $48M contract from the Air Force Research Laboratory to further advance the Insight system. Insight is a next-generation Intelligence, Surveillance, and Reconnaissance exploitation and resource management system which uses multiple intelligence signal processing, domain analysis multi-level fusion, predictive analytics, machine learning, and automation to fill gaps in today's military intelligence analysis capability.

10:00 EDT Jumia Technologies falls -42.9% - Jumia Technologies is down -42.9%, or -$4.54 to $6.05.

09:50 EDT Getty Images renews partnership with communication platform Canva - Getty Images announced the renewal of its partnership with Canva, a visual communication platform. The multi-year renewal will continue to provide Canva's customers with access to millions of Getty Images' creative image and video assets, the company said in a statement. The renewal also expands the partnership to support Canva's work to develop generative AI tools, as part of Canva's $200M Content Fund. Getty Images has partnered with Canva since 2018.

09:49 EDT Correction: Getty Images renews partnership with Canva - The partnership was not renewed with Carvana as previously reported.

09:48 EDT Lumen rises 46.7% - Lumen is up 46.7%, or $1.21 to $3.80.

09:48 EDT Teradata falls -16.2% - Teradata is down -16.2%, or -$4.73 to $24.42.

09:47 EDT Jumia Technologies falls -33.5% - Jumia Technologies is down -33.5%, or -$3.55 to $7.04.

09:42 EDT L B Foster trading resumes

09:38 EDT Regencell Bioscience Holdings Ltd trading halted, volatility trading pause

09:34 EDT Global Payments appoints Robert Cortopassi as COO - Global Payments announced the appointment of Robert Cortopassi, as its new president and chief operating officer, effective immediately. Cortopassi was previously senior executive vice president and president of international and vertical markets, where he was responsible for international merchant acquiring and multinational commerce, vertical market software businesses, and global product.

09:33 EDT Datasea subsidiary named prospective partner for China Mobile Internet projects - Datasea announced that on July 17, 2024, the Company's wholly-owned subsidiary, Heilongjiang Xunrui Technology, was selected by China Mobile Internet as a prospective partner in its database of companies, that may be chosen to sign specific project cooperation contracts. China Mobile Internet is a subsidiary of China Mobile. According to the announcement released on July 8, 2024 by China Mobile Internet regarding choosing prospective partners for the Database, Xunrui Technology will now be able to be selected to undertake specific projects for China Mobile Internet, leveraging the development and application of Datasea's advanced 5G-AI multimodal communication technologies. This collaboration aims to promote the joint development of communications and internet innovations, and has the potential to contribute to future revenue growth for Datasea.

09:31 EDT Azek enters long-term distribution partnership with Doman - Azek announced a long-term distribution partnership with Doman, a Canadian distributor. This strategic partnership will expand the availability of Azek's TimberTech brand of decking products to customers across Canada. Under this agreement, Doman will distribute TimberTech decking, known for its unparalleled performance, innovative technology, premium aesthetics and top-rated fire resistance. This partnership aligns with AZEK's commitment to expanding its market presence and providing Canadian customers with high-performance, environmentally sustainable decking solutions made from up to 85% recycled waste and scrap material.

09:29 EDT Core Scientific announces exercise of additonal contract option by CoreWeave - Core Scientific announced that CoreWeave, the AI Hyperscaler, has exercised its option to contract for additional infrastructure pursuant to the terms provided as part of the previously announced 200 megawatt hosting contract for high performance computing, or HPC, entered into with CoreWeave on June 3. Under the terms of the announced agreement, Core Scientific will modify its infrastructure to deliver approximately 112 incremental MW for HPC to host CoreWeave's Nvidia GPUs. Site modifications are expected to begin in the second half of 2024, with operational status anticipated in the first half of 2026. This new 12-year HPC hosting contract will further expand Core Scientific's exposure to contracted, multi-year, dollar-denominated revenue. The new contract with CoreWeave is expected to add approximately $2B in projected additional cumulative revenue over the hosting contract's 12-year term to the more than $4.7B in projected cumulative revenue associated with previously announced contracts with CoreWeave, for a total of $6.7B.

09:27 EDT Alzamend Neuro partners with Massachusetts General Hospital - Alzamend Neuro announced that it is partnering with Massachusetts General Hospital as its contract research organization to conduct first of its kind Phase II clinical study of AL001 for treatment of patients with BD.

09:25 EDT Marqeta announces five-year deal with Varo Bank - Marqeta announced it has signed a five-year deal with Varo Bank, N.A., the first nationally-chartered consumer techbank in the U.S., to become its issuer processor. Varo Bank offers services such as fee-free checking accounts, free ATM access at over 40,000 locations, cash advances and lines of credit, secured credit-building credit cards, instant payment solutions and high yield savings accounts to customers, with over five million cards in-market.

09:23 EDT Tejon Ranch to continue to invest in advancing residential projects - The company said, "The Company will continue to strategically pursue commercial/industrial development, multi-family development, leasing, sales, and investment within TRCC and its joint ventures. The Company also will continue to invest in advancing its residential projects, including Mountain Village at Tejon Ranch, Centennial at Tejon Ranch and Grapevine at Tejon Ranch. California is one of the most highly regulated states in which to engage in real estate development and, as such, natural delays, including those resulting from litigation, can be reasonably anticipated. Accordingly, throughout the next few years, the Company expects net income to fluctuate from year-to-year based on the above-mentioned activity, along with commodity prices, production within its farming and mineral resources segments, and the timing of land sales and leasing of land within its industrial developments. Water sales opportunities each year are impacted by the total precipitation and snowpack runoff in Northern California from winter storms, as well as State Water Project, or SWP, allocations. The current SWP allocation is at 40% of contract amounts, with the expectation that the allocation may increase. The Company's farming operations in 2024 continue to be impacted by higher costs of production, such as fuel costs, fertilizer costs, pest control costs, and labor costs. The Company is anticipating higher 2024 almond industry crop production, which may have an adverse effect on 2024 selling prices."

09:19 EDT Spectaire Holdings announces Nasdaq determination to delist the stock - On August 5, 2024, the Company received a letter from the NASDAQ Hearings Panel that, following the Company's hearing before the Panel on July 23, 2024, NASDAQ has determined to delist the Company's common stock and that trading in the Company's securities will be suspended from NASDAQ at the open of trading on August 7, 2024. It is anticipated that the Company's common stock will be subject to quotation and trading on the over-the-counter market as of August 7, 2024 under the Company's existing trading symbol "SPEC."

09:17 EDT Cadrenal Therapeutics and Abbott partner to develop anticoagulant tecarfarin - Cadrenal Therapeutics (CVKD), developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist oral and reversible anticoagulant designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with implanted cardiac devices and those with rare cardiovascular conditions, has been in discussions with Abbott (ABT) about Cadrenal's planned pivotal study of tecarfarin in patients with recently implanted LVADs. All patients with LVADs require lifelong anticoagulation to protect against thromboembolic events. In April 2024, tecarfarin received FDA Orphan Drug Designation to prevent blood clots and strokes in patients with implanted mechanical circulatory support devices such as LVADs. Currently, the only LVAD available in the United States is the HeartMate 3, manufactured by Abbott, which has been shown to be superior to all prior LVADs. Prior clinical studies provide evidence that tecarfarin yields improved AC quality, particularly in patients on multiple medications and those with impaired renal function, both of which are common in LVAD patients.

09:13 EDT Carrier Global and Sibi partner in solutions for HVAC supply chain - Carrier Global subsidiary Carrier and Sibi, a technology platform for supply chains, are collaborating to transform the HVAC industry through enhanced data-driven efficiency and the creation of a new optimized supply chain management system. As part of the agreement, Sibi's flagship integration products will connect home builders directly with Carrier's distribution channel partners. The platforms will allow channel partners to place orders for Carrier solutions directly through Sibi's interface. Additionally, through the agreement, Carrier will now have access to networks in the Single-Family Rental, Multi-Family Rental, Home Warranty and New Construction sectors. Furthermore, digital tools will now be made available to help enhance HVAC contractors' operations, providing instant access to a wide array of Carrier products and more.

09:10 EDT Microsoft integrates Marvell's new hardware security modules into Azure - Marvell (MRVL) announced that Microsoft (MSFT) - which uses the Marvell LiquidSecurity family of hardware security modules, or HSMs, to perform encryption, key management, and other security functions within Azure - will update its fleet of LiquidSecurity HSMs to the FIPS 140-3, Level-3 standard to further enhance its internal security posture and the portfolio of security services offered to its customers. Marvell LiquidSecurity 1 and LiquidSecurity 2 hardware security modules achieved FIPS 140-3 Level-3 certification from the National Institute of Standards and Technology in June, a set of security requirements established by National Institute of Standards and Technology and managed by both the United States and Canada. FIPS 140-3 introduces several new security enhancements over FIPS 140-2. HSMs perform the authentication and encryption processes behind secure key protection and management, credit card purchases, ATM withdrawals, sign-in services and other high-volume transactions. Revenue from cloud-based HSMs is expected to grow from under 15% today to over 40% by 2028, according to ABI Research.

09:09 EDT Varonis announces AI-powered data discovery, classification - Varonis Systems announced powerful new AI capabilities that enhance its industry-leading data classification engine. Using novel machine learning techniques, Varonis can automatically discover, understand, and classify customers' unique data better than ever. "Every Varonis customer is different, each with its own proprietary data types and formats," said David Bass, Varonis EVP of Engineering and Chief Technology Officer. "By combining the power of trainable AI classifiers and Varonis' battle-tested classification, organizations can reap the benefits of multiple techniques for maximum accuracy, performance, and cost."

09:08 EDT Sintx Technologies announces appointment of Olson as CEO - SINTX Technologies announced that its Board of Directors has appointed Eric Olson to succeed B. Sonny Bal, MD as the Company's Chief Executive Officer and President. Olson's appointment follows the Company's recent announcement that Dr. Bal was retiring from his position as Chief Executive Officer and President effective upon the appointment of a new chief executive officer and president by the Board of Directors. Dr. Bal will continue to serve as Chairman of the Board on the Company's Board of Directors. Most recently Olson was the Founder, Chief Executive Officer and Board Member of Foresite Innovations.

09:07 EDT Innoviz Technologies enters distribution agreement with The Indoor Lab - Innoviz Technologies entered into a distribution agreement with The Indoor Lab, a company in non-automotive LiDAR analytics, to deploy InnovizTwo LiDARs across its airport portfolio, beginning with Denver, Tampa, and Nashville International airports. This collaboration will enable airport partners with exceptional visibility and data analytics to help create a safer and more efficient environment for travelers.

09:05 EDT Freight Technologies integrates Fr8App with Tecnomotum platform - Freight Technologies announces its integration with Tecnomotum, one of the largest data transmission companies for haulage in Mexico. Tecnomotum provides customers with technology and information to increase security, reduce accident risks and optimize its comprehensive ecosystem for fleet connectivity and logistics transactions. This integration aims to maximize savings, enhance user experience, provide real-time data and streamline logistics operations. Understanding the necessity for comprehensive and reliable fleet connectivity, Fr8App integrated with Tecnomotum to provide additional value and enhanced capabilities to its users. Through this integration, users will have access to several functionalities, including current position, position history, messages, operational status and more.

09:03 EDT Clearmind Medicine announces publication on MEAI potential in weight loss - Clearmind Medicine announced that a new article published by Baraghithy et al, revealed promising results from a recent study on 5-methoxy-2-aminoindane for combating obesity. The study was meticulously conducted by a team of experts led by Prof. Joseph Tam, head of the Obesity and Metabolism Laboratory at the School of Pharmacy in the Hebrew University of Jerusalem. Key findings from the study include:Weight loss: MEAI significantly reduced diet-induced obesity in mice by decreasing fat mass while preserving lean mass. Improved Metabolism: MEAI significantly improved glycemic control by reducing hyperglycemia, glucose intolerance and hyperinsulinemia, highlighting its therapeutic potential in regulating glucose metabolism. Fatty liver disease: MEAI decreased fatty liver by lowering liver triglyceride and cholesterol levels, mainly through inhibiting new lipid synthesis and reducing fat accumulation. Increased Energy Expenditure: MEAI increased energy expenditure and fat utilization while maintaining a similar food consumption. Activity: MEAI increased activity-specific energy expenditure without overstimulation supporting its potential to impact energy balance. These findings are based on the results from Clearmind Medicine's study aimed to investigate the ability of MEAI to modulate metabolism and counteract obesity.

09:02 EDT Caterpillar says Q2 dealer inventory decreased vs. an increase in 2Q23 - Says demand in China for 10-ton excavator industry to remain at "relatively low level." Seeing "healthy demand" for used equipment. Sees FY24 CapEx $2B-$2.5B. Says balance sheet "remains strong." Comments taken from Q2 earnings conference call.

09:00 EDT H.B. Fuller acquires HS Butyl, terms undisclosed - H.B. Fuller announced that it has acquired HS Butyl, the UK's largest manufacturer and distributor of high-quality butyl tapes, which provide strong, permanent, watertight seals for a wide variety of applications within the construction, infrastructure, automotive and renewable energy industries. HS Butyl is a family-owned business that has been designing, engineering, and manufacturing butyl tape from its headquarters in Lymington, England, since its founding in 1964. With more than $23M in annual sales, HS Butyl exports to more than 50 countries around the world. The new business will operate within H.B. Fuller's Construction Adhesives global business unit.

08:50 EDT Yum! Brands sees FY24 operating profit growth 8% - Sees FY24 unit growth 5%. Sees FY24 gross openings similar to Q3. Sees Q3 G&A higher than last year. Sees FY24 operating profit growth 8%. Says continued challenging operating environment. Comments and guidance taken from Q2 earnings conference call.

08:48 EDT Inspire Veterinary reaffirms plans to accelerate acquisition, growth strategy - Inspire Veterinary Partners announced its commitment to accelerate its acquisition and growth strategy following its previously announced closing of a $6 million public offering. "We believe that we have the building blocks in place to help achieve the next phase of our acquisition strategy and do so while driving strong growth and shareholder returns," said Kimball Carr, President & Chief Executive Officer of Inspire. "We remain early in our growth journey, with our strong base of veterinary hospitals, proven ability to create enduring client/pet relationships, and significant runway in core, existing, and new markets. Following our recently completed and successful public offering, I am excited about taking our growth strategies to the next level to serve more and more pets around the nation. At the same time, we intend to combine financial discipline with a steady focus on revenue growth, gross margin expansion and strong cash flow to deliver compelling shareholder returns." New and existing strategic initiatives to drive sustainable revenue and earnings growth, including: Expansion in 2024 and 2025 through hospital acquisitions and new business integrations by targeting single unit acquisitions and the potential for multi-unit integrations; Scaling Inspire's service offerings by expanding its national veterinary care footprint to provide pet parents with unrivaled access to general and specialized health care services; Diversifying earnings streams through improved category and business mix; Building a differentiated merchandise offering through key vendor relationships; and Scaling personalization capabilities by leveraging the power of its comprehensive pet database and data-driven approach to enhance the pet parent experience, and deepen engagement and loyalty.

08:46 EDT Sellas Life Sciences receives EMA Orphan Drug Designation for SLS009 - SELLAS Life Sciences Group announced that the European Medicines Agency has granted Orphan Drug Designation for SLS009, a novel, and highly selective CDK9 inhibitor, for the treatment of relapsed/refractory peripheral T-cell lymphomas. In the completed dose-escalation portion of the Phase 1 trial in relapsed/refractory hematological malignancies, SLS009 demonstrated favorable safety/tolerability and promising clinical efficacy. Complete or partial responses were observed in AML and lymphoma patients, with a 36.4% response rate achieved specifically in the PTCL patient group, including one patient who remained in continuous treatment for over 56 weeks. The current standard of care for r/r PTCL, belinostat, showed in its pivotal Phase 2 study a 25.8% response rate in a similar patient population to that in the SLS009 Phase 1 clinical trial.

08:41 EDT Catheter Precision announces publication of LockeT data - Catheter Precision announced the publication of its first LockeT study in the Journal of Cardiovascular Electrophysiology. The study titled, Feasibility, safety and efficacy of a novel external compression vascular closure device: The LockeT Study, was made available online on August 5, 2024. The study demonstrates the first clinical use of LockeT in 102 patients utilizing 182 LockeT devices and suggests that LockeT is effective for hemostasis, and early ambulation can be achieved with no major complications. The use of LockeT appears to generate the same benefits as standard of care without needing prolonged bed rest or monitoring, facilitating early mobilization and same-day discharge. Highlights of the study include: Hemostasis was immediately achieved; Hemostasis remained at 2 hours in 98% of patients; No major complications were observed; The majority of patients were discharged same day; Average Time to ambulation was under 4 hours; Further studies with LockeT are underway and the next study is planned to be concluded this year with additional data.

08:40 EDT Expion360 partners with K-Z Recreational to provide lithium battery solutions - Expion360 (XPON) announced a partnership with K-Z Recreational Vehicles, a subsidiary of Thor Industries (THO). This collaboration will integrate Expion360's cutting-edge battery technology into K-Z RV's premium offerings, enhancing the off-grid capabilities of their vehicles.

08:39 EDT Complete Solaria discusses SunPower acquisition opportunity - Complete Solaria (CSLR) had received a coveted "Stalking Horse" position in the SunPower (SPWR) Chapter 11 bankruptcy. As the stalking horse bidder, Complete Solaria enjoys some benefits in the Chapter 11 legal process, including setting the first bid, and, more importantly, the right to negotiate the Asset Purchase Agreement with the SunPower team. The third-generation plan of our jointly created APA describes a new company created with the top employees from three solar companies from Salt Lake's "Solar Valley," the home to over 20 solar companies. The three companies are Blue Raven, Complete Solaria and Core Energies. These three companies would then combine with SunPower's expensive but very competent organization to become a cost-competitive solar power-house. The plan lowers our current headcount from 2587 to 1273, while still retaining our key Silicon Valley brain trust. T.J. Rodgers, Complete Solaria CEO, said, "I became CEO of Complete Solaria for arguably humanitarian reasons, I'm 76 years old and the world left a crying CEO-less baby on my doorstep. Now, I'm hooked on Complete Solaria. While my silicon world was more complex and technical, my solar world has technological components - intriguingly combined with bare-knuckle, cash-flow, live-or-die economics. I'm in."

08:37 EDT Lucas GC signs strategic agreement with Industrial Securities - Lucas GC Limited announced that it has signed a strategic partnership agreement with Industrial Securities Co., Limited, one of the leading financial institutions in China, to develop AI solutions to boost productivity of financial advisors in selling financial products to customers. Howard Lee, Chief Executive Officer of Lucas, said "Our patented technologies in AI and data analytics are capable of vastly improving the financial product recommendations accuracy. The most imminent application is in the wealth management business. Our technologies will bring benefits to both the financial institution and the customer as the financial institution is more effective on customer interactions and the customer will get better fit recommendations on wealth management products based on the customer's profile and behaviors."

08:37 EDT Trump Media announces launch of TV streaming on Android devices - Trump Media & Technology Group launched linear TV streaming on Android devices. Without needing to update their apps, Android users can now access TV streaming on the Truth Social app by clicking on a Truth+ streaming icon shaped like a TV. Users can view streaming content as stand-alone channels or in a separate picture-in-picture window while scrolling on the Truth Social platform. The launch, powered by TMTG's new, custom-built content delivery network, comes shortly after the introduction of TV streaming on the Web version of Truth Social, truthsocial.com.

08:36 EDT CSW Industrials deploys $40M for PSP Products acquisition - CSW Industrials announced the strategic acquisition of PSP Products, deploying $40M. This acquisition further demonstrates the Company's commitment to allocate capital to leverage our powerful HVAC/R distribution channel to extend our offering of products to our customers. CSWI funded the transaction with cash on hand and borrowings under its existing $500 million revolving credit facility. The acquisition of PSP Products, Inc. brings a family of superior surge protection and load management products to CSWI. PSP utilizes a differentiated technology approach to its electrical management devices to ensure reliability, vigor, and strength. All PSP surge protection devices are designed, tested and built to perform in extreme conditions for decades. PSP is the industry leader in load management systems, offering novel products which make generator installation jobs easier and more profitable. The $40 million of capital for the acquisition of PSP, including estimated working capital adjustments but excluding future earn-outs, represents a valuation of approximately 5.0x PSP's trailing twelve-month adjusted earnings before interest, taxes, depreciation, and amortization

08:32 EDT RDE to begin trading on Nasdaq Capital Market on August 7 - RDE announced it has received approval for its common shares to trade on the Nasdaq Capital Market effective at market open on August 7th, 2024. RDE, Inc. shares previously traded on the OTC Markets' OTCQB level. The Company's ticker "RSTN" will remain unchanged.

08:27 EDT TFF Pharmaceuticals provides continued positive outfomes from TFF TAC - TFF Pharmaceuticals provided an update from the Company's ongoing Phase 2 trial of Tacrolimus Inhalation Powder, TFF TAC, for the prevention of lung transplant rejection. "The growing body of data from the TFF TAC Phase 2 study continues to suggest that TFF TAC has transformative potential to advance the field of immunosuppressive therapy to prevent lung transplant rejection," said Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals. "We are finalizing the design of the next study with TFF TAC in close collaboration with our clinical investigators and in communication with regulatory authorities and look forward to providing additional updates on the program including a regulatory update later in the fall."

08:26 EDT Science 37 unveils new corporate HQ in Research Triangle Park, NC - Science 37 announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park. The new facility, will serve as a hub for all Science 37 operations, enabling cross-functional teams with greater opportunities for collaborative problem-solving and integrated solution delivery. Centralizing operations in one facility will enable Science 37 to deliver patient recruitment and study conduct support on behalf of clinical trial sponsors with greater consistency, speed, and quality.

08:26 EDT Uber says having 'lots of discussions' with AV players - Does not expect substantial profit from AV's within next 5-10 years. Says electrification of fleet a "very important initiative." Says looking to partner with BYD on EV's and AV's. Says has "great confidence" in mobility business. Says grocery continues to be a strong story for delivery business. Says long-term growth potential of delivery business in grocery/retail is "incredibly promising."

08:25 EDT Alight CEO Stephan Scholl to step down - In line with the closing of the payroll and professional services sale, the company announced that Stephan Scholl will step down as CEO and member of the board, effective after the board names a successor. Scholl will continue as CEO and director during the search process. In addition, the board has appointed Dave Guilmette, an independent director, as vice chair of the board. In this role, he will work closely with Scholl to ensure a transition.

08:23 EDT Horizon Aircraft announces research on investment allocation over next 12 months - New Horizon Aircraft publishes new global research that indicates fund managers that invest primarily in small-cap and micro-cap stocks believe there will be an increased level of exposure to small and micro-caps from both institutional and retail investors over the year ahead. The global study with small and micro-cap fund managers in the US, Canada, Europe, the Middle East and Asia with collectively $82.4 billion assets under management, found that 76% of respondents anticipate the level of exposure to small and micro-caps from institutional investors to increase over the next six to 12 months. One in three fund managers believe allocations could increase by 25% or more. The findings also reveal that 83% of fund manager respondents expect retail investors to increase their allocation of small and micro-caps over the next six to 12 months. Over half of respondents believe that the allocation could increase by more than 25%, and one in eight believe that exposure to small and micro-caps could rise by more than 50%. One in three fund managers describe the current level of exposure from institutional investors to both small- and micro-caps as being underweight, with 21% of respondents describing the allocation to micro-caps as being "slightly underweight" and 11% describing it as being "extremely underweight". Institutional investors' current level of exposure to small-caps and micro-caps is described as being overweight by 4% and 23%, respectively. A similar picture is seen with retail investors, with fund managers describing this group's allocation to small-caps and micro-caps as being underweight and as being overweight

08:22 EDT Super League, Meta-Stadiums partner to expand cross-platform experiences - Super League announced a strategic partnership to combine capabilities and offer cross-platform immersive experiences and events to music artists, sports teams, entertainment companies, and consumer brands. The alliance creates a world-class end-to-end provider of metaverse programs and strategies that reaches all corners of the virtual universe, from bespoke 3D spaces to the most popular immersive platforms such as Roblox, Fortnite Creative, The Sandbox, Decentraland, and Minecraft.

08:20 EDT aTyr Pharma appoints Jayant Aphale as VP, technical operations - aTyr Pharma announced the appointment of Jayant Aphale, Ph.D., as Vice President, Technical Operations. Dr. Aphale will serve as a member of the Company's executive leadership team, overseeing manufacturing activities at contract development and manufacturing organizations and implementing strategies related to the continuous improvement of commercial manufacturing, supply chain management, process development of new products and product life cycle management. Prior to joining aTyr, Dr. Aphale was Vice President, RNA Manufacturing & Process Development for Sarepta Therapeutics

08:18 EDT Tonix Pharmaceuticals announces publication on antibodies against SARS-CoV-2 - Tonix Pharmaceuticals announced the publication of a research paper in Microorganisms, a scientific, peer-reviewed, open access journal of microbiology. The article titled, "High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization," by Kota, et al.1, highlights proprietary high-throughput, high-content imaging technology to screen convalescent sera for generating neutralizing, fully-human monoclonal antibodies against SARS-CoV-2 variants and potentially other pathogens. "This article highlights Tonix's capabilities in developing fully human mAbs against SARS-CoV-2 and other pathogens," said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. "Our phenotypic imaging system can be used to identify antibodies to counter SARS-CoV-2 and its variants and potentially other infectious agents."

08:17 EDT Lucid Diagnostics' EsoGuard esophageal precancer testing shows efficacy - Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), announced the release of new real-world data from its ENVET-BE study supporting the clinical utility of the EsoGuard Esophageal DNA test as a non-invasive triage tool to significantly increase the positive yield of invasive upper endoscopy - EGD -. for detection of esophageal precancer and cancer. Patients triaged to invasive EGD following a positive non-invasive EsoGuard test had a 2.4-fold increase in the positive yield of those EGDs compared to the expected yield of screening EGD alone in at-risk patients. EGD confirmed a BE diagnosis in 50 of the 199 patients in a real-world commercial setting who underwent clinically directed EsoGuard testing and received a positive EsoGuard result. This represents a post-triage EGD yield of 25%, a 2.4-fold increase over the expected 11% yield of EGD as a standalone screening tool in the at-risk population. These findings are consistent with those previously published in the American Journal of Gastroenterology for a study conducted at the Cleveland VA that utilized EsoGuard for screening high-risk veterans.

08:16 EDT Compass Therapeutics completes patient enrollment in COMPANION-002 - Compass Therapeutics announced that it completed enrollment of the planned 150 patients in COMPANION-002, its randomized Phase 2/3 clinical trial of CTX-009 in patients with BTC. "We are very pleased to announce this enrollment milestone for the COMPANION-002 trial. We extend our deep gratitude to all the patients, families, and caregivers who are participating in the study. We would also like to thank the principal investigators, study coordinators, the Cholangiocarcinoma Foundation, and the clinical team at Compass for their dedicated support and hard work." said Thomas Schuetz, MD, PhD, Co-founder, CEO, and Vice Chairman of the Compass Board of Directors.

08:13 EDT L.B. Foster board approves modification to share repurchase program - The Company announced that its Board of Directors approved a modification to the previously-announced $15 million stock repurchase program, with $11.0 million remaining as of quarter end. The modification shortens the tenure to two years and removes the trailing-twelve month spending restriction, increasing flexibility to repurchase a greater amount of stock through the program expiration.

08:10 EDT Protara Therapeutics sees cash runway into 2026 - As of June 30, 2024, cash, cash equivalents and investments in marketable debt securities totaled approximately $89.6 million, which includes approximately $42.0 million in net proceeds from the April 2024 private placement. The Company expects its cash, cash equivalents, and investments in marketable debt securities will be sufficient to fund its planned operations and data milestones into 2026.

08:08 EDT Portillo's reaffirms long-term revenue growth target of mid teens - Sees long-term unit growth 12%-15%, same-restaurant sales up low single digits and adjusted EBITDA growth of low teens.

08:07 EDT Portillo's sees FY24 same-restaurant sales growth flat to slightly positive - See unit growth of 10+ new units, commodity inflation up mid-single digits and labor inflation up mid-single digits. Sees restaurant-level adjusted EBITDA margin 23%-24%, G&A expenses $82M-$84M, pre-opening expenses $10M-$10.5M, capex $85M-$88M.

08:05 EDT Southwest Gas sees 2024 net income $233M-$243M

08:04 EDT Cogent Biosciences expects cash to fund operations into 2027 - Cash Position: As of June 30, 2024, cash, cash equivalents and marketable securities were $389.9 million, as compared to $435.7 million as of March 31, 2024. The company expects its existing cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements into 2027 and through clinical readouts from ongoing SUMMIT, PEAK, and APEX registration-directed trials.

08:02 EDT Oracle opens second public cloud region in Saudi Arabia - To meet the rapidly growing demand for its AI and cloud services, Oracle announced the opening of its second public cloud region in Saudi Arabia. The new Riyadh cloud region will help public and private sector organizations migrate all types of workloads to Oracle Cloud Infrastructure, giving them access to a wide range of cloud services to modernize their applications and innovate with data, analytics, and AI. Center3 is the host partner for the new Oracle Cloud Riyadh Region.

07:53 EDT Fastenal reports July net sales up 10.5% to $633.84M - Fastenal reported July net sales were up 10.5% from last year to $633.836M and that daily sales were up 0.5% to $28.811M. Reference Link

07:51 EDT Acreage Holdings commences non-medical cannabis sales in Ohio - Acreage announced the launch of non-medical cannabis sales in Ohio. Beginning today, non-medical consumers in Ohio who are 21+ can purchase cannabis products from The Botanist locations in Akron, Canton, Cleveland, Wickliffe, and Columbus. "The launch of Ohio's non-medical market and our experience in the state represents a transformative opportunity which, combined with our recent capitalization, positions us for sustained growth," said Dennis Curran, Chief Executive Officer of Acreage. "With The Botanist dispensaries already well known for their expertise and commitment to quality, we are excited to introduce this popular brand to a fresh demographic of Ohioans. We also look forward to the opportunity to collaborate with our Canopy USA partners to bring the best of Wana's edibles and Jetty's solventless vapes to consumers across the state as we demonstrate the potential of this brand-driven ecosystem we are proud to be joining."

07:47 EDT Ayr Wellness launches adult-use sales in Ohio - AYR Wellness announced the launch of retail adult-use cannabis sales in Ohio, where individuals over the age of 21 with a valid government-issued photographic ID can now shop at AYR Dispensary locations in Woodmere, Goshen and Dayton.

07:45 EDT Iris Energy mined 222 bitcoin in July - July operations: Average operating hashrate impacted by: Planned outages for Phase 1 substation upgrades and Phase 2 substation energization; T21 miner performance due to a batch production issue, Bitmain is in the process of replacing all defective units; Increased electricity costs in July were primarily attributable to higher energy hedge pricing in the summer month at Childress, but with much lower than expected energy market volatility which reduced energy trading opportunities; The Company is re-assessing its future energy pricing structures ; Current fleet efficiency of 24 J/TH is expected to improve to 17 J/TH by the end of next month as part of the expansion to 20 EH/s

07:41 EDT ADC Therapeutics sees cash runway into mid-2026 - As of June 30, 2024, cash and cash equivalents were $300.1 million, compared to $278.6 million as of December 31, 2023. In May 2024 the Company completed an underwritten offering resulting in net proceeds of approximately $97.4 million, extending the expected cash runway into mid-2026.

07:36 EDT Anavex sees cash runway of four years - Cash and cash equivalents of $138.8 million at June 30, 2024 compared to $151.0 million at fiscal yearend September 30, 2023. The Company anticipates at the current cash utilization rate a runway of approximately 4 years.

07:36 EDT Black Diamond Therapeutics reports Q2 EPS (36c), consensus (39c) - "We continue to execute on enrollment of patients with EGFR mutant NSCLC into second/third-line and first-line Phase 2 cohorts, and remain on track to announce initial results later in the third quarter of this year and in the first quarter of 2025, respectively", said Mark Velleca, M.D., Ph.D., Chief Executive Officer of Black Diamond Therapeutics. "We also look forward to sharing analyses of real world data at the 2024 ESMO Congress in September 2024 on treatment practices and therapeutic outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations that demonstrate a significant unmet medical need."

07:33 EDT LeddarTech enters credit facility amendment, receives Nasdaq deficiency notices - LeddarTech entered into an Eleventh Amending Agreement with Federation des caisses Desjardins du Quebec with respect to the Amended and Restated Financing Offer dated as of April 5, 2023. As previously announced by the Company on July 5, 2024, pursuant to a Ninth Amending Agreement to the Desjardins Credit Facility, the Company was required to maintain an unencumbered cash balance of C$3.5 million from July 5, 2024 through July 6, 2024, and C$1.8 million from July 7, 2024 through July 26, 2024. Pursuant to a Tenth Amending Agreement to the Desjardins Credit Facility dated July 26, 2024, Desjardins had temporarily reduced the required Minimum Cash Covenant to C$1.3 million from July 26, 2024 through August 5, 2024, after which time the Company was to be obligated to maintain a minimum cash balance of C$5.0 million. Pursuant to the Amendment and Waiver, among other things, Desjardins has agreed to: temporarily reduce the required Minimum Cash Covenant to C$250,000 from August 6, 2024 through August 14, 2024, C$1,000,000 from August 15, 2024 until the earlier of the Short-Term Outside Date and November 15, 2024, and C$5,000,000 at all times after the earlier of the Short-Term Outside Date and November 15, 2024; and temporarily postpone payment of interest for the months of July, August, September and October 2024 until the earlier of the date of disbursement of an equity investment in the Borrower for a minimum gross proceeds amount of US$35,000,000 and November 15, 2024. The Amendment and Waiver provides for a monthly payment by the Company to Desjardins of C$125,000 until the Short-Term Outside Date, which payments will be due and payable on the earlier of the Short-Term Outside Date and November 15, 2024. The Company also announces that it has received notices from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company did not comply with the following Nasdaq Listing Rules within certain time periods as required for continued listing on the Nasdaq Global Market: minimum bid price of US$1.00 per share, minimum market value of publicly held shares of US$15,000,000, and minimum market value of listed securities of US$50,000,000. The Notices also indicated that the Company will be afforded a period of 180 calendar days to regain compliance. The Company intends to actively monitor the closing bid price, the MVPHS and the MVLS of its common shares and will evaluate available options to regain compliance with the Listing Requirements. However, there can be no assurance that the Company will be able to regain compliance with such Listing Requirements or maintain compliance with any of the other Nasdaq Global Market continued listing requirements. The Notices have no immediate effect on the listing of the Company's common shares, which will continue to be listed and traded on the Nasdaq Global Market under the symbol "LDTC," subject to the Company's compliance with the other continued listing requirements of the Nasdaq Global Market.

07:28 EDT Hillman CEO Doug Cahill to become chairman, COO Jon Michael Adinolfi named CEO - Hillman Solutions announced that Jon Michael Adinolfi, Hillman's current COO, will transition to the role of President and CEO; and Doug Cahill, Hillman's current Chairman, President, and CEO, will transition to the Role of Executive Chairman effective January 1, 2025. This planned leadership succession ensures the continuity of Hillman's current leadership and strategy.

07:26 EDT Asante provides update on sulphide plant, rerouting of Bibiani-Goaso Highway - Asante Gold announced a progress update related to the planned sulphide treatment plant and rerouting of the Bibiani-Goaso Highway at the Bibiani Gold Mine. Installation of the sulphide plant is key to the Company's plans to grow gold production at Bibiani to more than 250,000 ounces per year. Cumulative production of 1.2 million ounces of gold is anticipated over the next five years at lower all-in sustaining costs, as detailed in the 2024 Bibiani Technical Report. The plant is planned for completion in the first quarter of 2025, at a total capital cost of approximately $30 million. Once in operation, gold recovery from sulphide ore processed at Bibiani is expected to increase from 70% to approximately 92%, resulting in increased gold production and lower AISC. On this basis, the estimated payback on the sulphide plant is expected to be just four months. The sulphide plant is a unit operation that will be integrated with the existing process plant. It will include rougher flotation to produce a sulphide concentrate that is 10% of total process plant feed. This concentrate will be thickened and reground to 25 microns in order to liberate gold that occurs at 35 microns or more. Following this, the material will be treated with high-intensity leach, after which the tailings will be returned to the main carbon-in-leach plant. Installation of the sulphide plant continues to advance on schedule and within budget, with civil works now 55% complete. Long-lead time equipment was ordered in 2022, including the flotation equipment, thickener, grinding mill and the associated structural steel for the regrind section. Shipment of these items will start in mid-August 2024, with delivery to the Bibiani site starting in September 2024. In addition, other relevant equipment including pumps, instrumentation, switchgear, Aachen reactor, and leach tank agitators are being ordered at this time. All other structural steel and platework for the project will be fabricated in Ghana. As far as energy needs are concerned, the additional connected power load is approximately 3.5 megawatts, with an operating load of 2.4 megawatts. Detailed engineering is being progressed by Mining Process and Project Engineering, a Ghanaian engineering company. The Project Execution Plan has been developed and issued by Jet-Rom, the Ghanaian project management company, which estimates six months for completion. When the sulphide plant is completed, Asante expects to be producing approximately 20,000 ounces per month at Bibiani, which is in line with the Company's long-term planning for the mine. Asante looks forward to the completion of the sulphide plant as it works to improve and optimize its operating mines. Traffic was redirected onto the new road constructed to maintain access to Bibiani-Goaso Highway on June 3, 2024. This allowed closure of the portion of the road impacted by the mine's expansion plans. As previously announced, rerouting the highway allows the Company to access 170,000 ounces of contained gold from the main pit in the next 12 months. This ore was previously inaccessible. The Company completed its first pass of grade control drilling on June 10, 2024 and started to deliver oxide ore to the process plant on June 14, 2024. To date this oxide ore has yielded gold recovery of approximately 85% through the process plant. In addition to improved gold recovery in the short-term, mining south at the main pit of Bibiani defers full processing of sulphide ore until the sulphide plant is completed. This will allow Asante to recover approximately 92% of the gold in the sulphide ore, compared to the current recovery rate of approximately 70%.

07:23 EDT Seres Therapeutics signs VOWST asset purchase agreement with Nestle Health - Seres Therapeutics announced that it signed an agreement with Societe des Produits Nestle S.A for the sale of its VOWST business to Nestle Health Science. Upon deal closing, Seres will receive capital infusions, including an upfront payment, a prepaid milestone payment and an equity investment. In addition, Seres is due to receive installment payments in 2025, as well as potential future payments based on VOWST net sales targets. Seres will support ongoing VOWST availability by providing transition services through the first quarter of 2025 and manufacturing support through the end of 2025 and will continue to share 50/50 in the profit and loss of the business through the end of 2025. The completion of the transaction, which is subject to Seres' shareholder approval and other customary conditions, is expected to occur in the next 90 days. Under the terms of the agreement, Seres is due to receive: Payment of $100M, less approximately $20M in settlement of net obligations payable to Nestle at closing; Prepayment of a $60M milestone payment at closing; Installment payments of $50M in January 2025, and $25M (less up to approximately $1.5M in employment related payments to Nestle), in July 2025, subject to Seres' material compliance with transition obligations. Future milestone payments based on VOWST worldwide net sales as follows: $125M upon achievement of annual worldwide net sales of $400M; and $150M upon achievement of annual worldwide net sales of $750M.

07:22 EDT Stagwell to acquire Consulum, terms undisclosed - Stagwell announced it has entered into an agreement to acquire Consulum, a pan-MENA government advisory consultancy. The acquisition - Stagwell's second in MENA in 2024 - establishes a foothold for Stagwell in the Middle East. Founded in 2012, Consulum has grown to a team of approximately 160 professionals specializing in strategic communications, public policy, and leadership support, with offices in Riyadh, Manama, Dubai, London, Cape Town, and Kuala Lumpur.

07:21 EDT Okyo Pharma granted European Patent covering OK-101 - OKYO Pharma Limited announced today the grant of a key European Patent entitled: "Compositions Comprising Chemerin Analogs and Methods of Use". The present disclosure that lists Raj Patil, Chief Scientific Officer of OKYO Pharma as a joint Inventor, relates to novel OK-101 chemerin analogs for use in treating various diseases and conditions including but not limited to, ocular inflammatory and pain conditions, strengthening the Company's intellectual property position in this field.

07:20 EDT European Wax Center appoints Hunter to board of directors - European Wax Center announced the appointment of Julia Hunter to its Board of Directors ("Board"), effective August 1, 2024 Hunter will serve on the Nominating and Governance committee. Hunter joins the European Wax Center Board currently serving as the CEO of luxury California lifestyle and fashion brand Jenni Kayne.

07:18 EDT American Shared announces patients treated at Radiation Therapy Facility - American Shared Hospital Services announced that it has begun treating patients at its Radiation Therapy Facility, A.B. Radiocirugia y Radioterapia de Puebla, in Puebla, Mexico, located 80 miles from Mexico City. AMS has a Joint Venture agreement with the principal owners of Guadalupe Amor Y Bien to treat public and private cancer patients at A.B. AMS and Guadalupe hold 85% and 15% ownership interests, respectively, in A.B. Under the agreement, AMS has provided an Elekta Versa HD linear accelerator, an upgrade to Guadalupe's previous, older linac, and Guadalupe was accountable for all site modification costs.

07:13 EDT Creative Realities announces siginage with Sports & Entertainment venues - Creative Realities announce its strategic momentum and growth in the Sports and Entertainment vertical. Creative Realities has been pivotal in transforming stadium and arena technology solutions and the way sports and entertainment venues engage with their audiences. Leveraging its advanced digital signage and CMS platform solutions, the company is providing venues with flexible, tailored packages that include IPTV, food and beverage integration, and enhanced fan engagement experiences. These solutions not only maximize sponsorship revenue but also provide ongoing content strategy and hardware procurement services.

07:07 EDT Builders FirstSource authorizes $1B share repurchase plan - Builders FirstSource announced that on August 5 its Board of Directors authorized the repurchase of up to $1B of the Company's outstanding shares of common stock. "After completing nearly $1 billion of share repurchases in the second quarter, the Board's announcement of a new share repurchase authorization reflects our strong conviction in the Company's strategy, operating model, and fortress balance sheet underpinned by robust free cash flow generation, especially considering our confidence in the strength of the housing industry due to being underbuilt and favorable demographic trends," said Paul S. Levy, Chairman of Builders FirstSource. "The Company's industry-leading value-added solutions and digital tools, operational excellence, and prudent capital deployment will continue to compound growth and value for our shareholders."

07:04 EDT NeuroMetrix implements wind down of ADVANCE business - The Company implemented a wind down of its legacy ADVANCE business, which has been managed for cash flow for the past 5 years. This will free up resources and reduce IT overhead that had become an operational burden relative to the product's declining financial contribution.

07:02 EDT NeuroMetrix provides update on review of strategic options - The company said, "In February of this year, the Company announced that it had initiated a review of strategic options with an objective of enhancing shareholder value. Over the past six months, the Company has invested considerable effort in evaluating a number of specific strategic directions and also making financial, operational and commercial optimizations. In collaboration with a financial advisor, the Company conducted an extensive survey of potential transactions. Detailed diligence was performed on multiple opportunities; however, the Company determined that none of these opportunities were in the best interests of its shareholders at this time. The Company implemented a substantial reduction-in-force at the end of Q1 to lower operating expenses by over $0.5M per quarter. The Company has been exploring opportunities to monetize certain assets to offset operating cash consumption. Particular attention has been placed on international markets that are not central to the Company's domestic sales focus. The Company engaged in discussions with one of its largest shareholders that led to the addition of Joshua S. Horowitz as a new independent director and termination of its at-the-market (ATM) equity facility in April 2024. The Company believes it is in the best interests of shareholders that the strategic review process continues. There can be no assurance that this process will result in the Company pursuing or consummating any particular transaction or other strategic outcome. The Company has not set a timetable for completion of this evaluation process and may not disclose further developments unless disclosure is appropriate or necessary."

06:49 EDT Merck, Daiichi Sankyo enter commercialization agreement for MK-6070 - Daiichi Sankyo and Merck have expanded their existing global co-development and co-commercialization agreement for three investigational DXd antibody drug conjugates to include Merck's MK-6070, an investigational delta-like ligand 3 targeting T-cell engager. The companies will jointly develop and commercialize MK-6070 worldwide, except in Japan where Merck will maintain exclusive rights. Merck will be solely responsible for manufacturing and supply for MK-6070. Under the terms of the agreement, Merck will receive an upfront cash payment of $170M and has also satisfied a contingent quid obligation from the original collaboration agreement. The companies will share R&D and commercialization expenses as well as profits worldwide, except for Japan where Merck retains exclusive rights and Daiichi Sankyo receives a royalty based on sales. R&D expenses related to MK-6070 in combination with ifinatamab deruxtecan will be shared in a manner consistent with the original agreement for ifinatamab deruxtecan. Merck will generally record sales for MK-6070 worldwide.

06:30 EDT Clarivate CEO Jonathan Gear to step down, Matti Shem Tov to succeed - Clarivate announced that the board has appointed Matti Shem Tov, former CEO of ProQuest, as the company's next CEO, effective August 9. Shem Tov will also join the company's board of directors. Jonathan Gear, CEO, will step down as CEO and as a member of the board at that time, and will transition into a non-executive role until November 1.

06:26 EDT Clear Secure sees FY24 free cash flow up 40% - The company said, "For the full year of 2024, we expect to deliver strong revenue and Total Bookings growth, expanding margins and Free Cash Flow growth of at least 40% versus 2023."

06:21 EDT Edgewell Personal Care appoints Dan Sullivan COO, Francesca Weissman CFO - Edgewell Personal Care announced key changes to its executive leadership team, including the appointments of COO and a new CFO. Dan Sullivan, currently CFO and president of Europe and Latin America, has been appointed to the position of COO, effective immediately. Sullivan will continue to serve as CFO until December 1. In his role as COO, Sullivan will be responsible for continuing to drive and grow the company's international markets under a newly consolidated international business. Francesca Weissman, currently senior VP of finance and business strategy, will assume the role of CFO effective December 1. Weissman will report to Sullivan and continue to lead all aspects of corporate FP&A and commercial and operational finance.

06:18 EDT NCR Voyix cuts FY24 revenue view to $2.805B-$2.86B from $3.6B-$3.7B - FY24 consensus $3.63B. Cuts FY24 adjusted EBITDA view to $355M-$375M from $632M-$657M. "The company is updating its full year 2024 guidance to reflect the strategic announcements described above, including the classification of our Digital Banking business as a discontinued operation beginning in the third quarter of fiscal 2024 as a result of the planned divestiture, which results in the removal of Digital Banking results from our outlook and results of operations for the full year and all prior periods."

06:05 EDT NCR Voyix to sell cloud-based digital banking business to Veritas for $2.45B - NCR Voyix announced the signing of a definitive agreement under which an affiliate of Veritas has agreed to acquire NCR Voyix's cloud-based digital banking business for $2.45B in cash plus future additional contingent consideration of up to $100M. NCR Voyix's digital banking platform is currently the largest independent platform of its kind in the United States. This transaction is part of the company's ongoing efforts to streamline its operations to focus specifically on its core software and services offerings for restaurants and retailers around the world. NCR Voyix expects to use the proceeds of the transaction to accelerate the achievement of certain financial objectives, including de-levering the balance sheet, which will enable greater strategic investment in the company's core businesses. The transaction has been approved by NCR Voyix's board of directors and is expected to close by year-end, subject to customary closing conditions, including regulatory approvals. Pursuant to the terms of the definitive agreement, Veritas will acquire the assets of the NCR Voyix Digital Banking business for a purchase price of $2.45B plus future additional contingent consideration of up to $100M.

06:01 EDT Henry Schein announces new restructuring plan - Henry Schein is announcing a restructuring plan to integrate recent acquisitions, right-size operations and further increase efficiencies, targeting $75 million to $100 million in annual run-rate savings. The Company expects to record restructuring charges in the second half of 2024 and in 2025; however, an estimate of the amount of these charges has not yet been determined as plans are still being finalized. Restructuring charges are expected primarily to include severance pay and facility-related costs. The restructuring plan announced in the third quarter of 2022 was completed on July 31, 2024.

05:46 EDT SunPower files for Chapter 11, to sell Blue Raven Solar to Complete Solaria - SunPower (SPWR) announced it has entered into an asset purchase agreement with Complete Solaria (CSLR) to serve as the Stalking Horse Buyer for the assets associated with SunPower's Blue Raven Solar business, New Homes business, and non-installing dealer network. Concurrently, the company and certain of its subsidiaries filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware, which will provide other interested parties the opportunity to submit competing bids for the company's assets. Under the terms of the APA, subject to court approval, Complete Solaria will acquire the assets and assume certain related liabilities for $45M in cash. The company has asked the court for approval to complete the transaction mid to late September. Additionally, SunPower intends to continue a sale process for its remaining assets and effectuate any resulting sale transactions pursuant to Section 363 of the U.S. Bankruptcy Code. SunPower has requested court approval to access the necessary prepetition cash collateral to fund business operations and administrative expenses during the Chapter 11 cases. To support its operations during the court-supervised process, the company is filing a variety of customary motions seeking, among other things, authorization to meet its obligations to its employees. The company expects to receive court approval for these requests. Following an expeditious sale process, the company plans to liquidate any remaining assets and undergo an orderly and efficient winddown of its operations.

05:33 EDT Hafnia provides update on redomiciliation to Singapore - Reference is made to the stock exchange announcement made by Hafnia on July 22 regarding the board of directors proposal to implement a scheme of arrangement between the company and its shareholders pursuant to Section 99 of the Bermuda Companies Act 1981 as amended in order to effect a discontinuance of the company from Bermuda and continuance to Singapore. The Supreme Court of Bermuda held a hearing where the court was asked to give directions as to the convening of a meeting of shareholders of the company that are eligible to vote on the scheme. The court ordered that the scheme meeting be held on September 11. Shareholders of record at the close of trading on August 6 are entitled to receive notice and to vote at the scheme meeting in respect of the number of shares registered in their name at the record date. The notice of the scheme meeting and an explanatory statement will be provided in due course.

05:21 EDT Elbit Systems awarded $270M supply contract - Elbit Systems announced that it was awarded a contract worth approximately $270 to supply rocket artillery to an international customer. The contract will be performed over a period of four years.

05:14 EDT UMC reports July revenue NT$20.9M, up 9.61%

05:09 EDT Quoin Pharmaceuticals initiates QRX003 study - Quoin Pharmaceuticals announced the planned initiation of an investigator-led clinical study in New Zealand to evaluate the safety and efficacy of QRX003 in a pediatric patient with Peeling Skin Syndrome, or PSS. QRX003 is Quoin's most advanced pipeline product and is currently being evaluated in two late stage clinical trials in the United States as a potential treatment for Netherton Syndrome, or NS. Both studies are being conducted under an open investigational new drug, or IND, application with the FDA.

04:59 EDT Teradata to cut 9% to 10% of global workforce in restructuring - Teradata announced last night that it has realigned its sales function and initiated global restructuring and cost reduction actions "to optimize operations, reduce non-revenue generating expenses, and drive efficiencies for long-term growth and profitability," resulting in a reduction of approximately 9% to 10% of its global workforce that is expected to result in: Operating expenses reducing by approximately $75M to $80M on an annualized run rate. Teradata expects to re-invest a portion of this amount back into revenue generating growth areas; Total cash expenditures from severance payments of approximately $45M to $50M, of which payments in 2024 are approximately $30M to $35M. The remaining payments will be made in 2025; on-GAAP operating profit to benefit by approximately $15M to $20M in 2024.